Company: BLTE
Filing Date: 2025-12-02
Form Type: 424B5
Source: 0001104659-25-117702
Chunk: 16

Company: BELITE BIO, INC
Filing Date: 2025-12-02
Form: 424B5
Chunk 16
---
2025, the market value of the ADSs held by non-affiliates exceeded US$700.0 million. As a result, as of December 31, 2025, we will be a “large accelerated filer” under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and we will no longer qualify as an “emerging growth company” and we will no longer be able to avail ourselves of certain reduced reporting requirements applicable to emerging growth companies.

<div align='center'>S-9</div>

TABLE OF CONTENTS

### THE OFFERING

#### ADSs offered by us
2,272,727 ADSs, each representing one ordinary share, par value US$0.0001 per share.

#### Option to purchase additional ADSs
We have granted the underwriters an option, exercisable within 30 days from the date of this prospectus supplement, to purchase up to an aggregate of 340,909 additional ADSs.

#### The ADSs
Each ADS represents one ordinary share. The ADSs initially will be delivered by Deutsche Bank Trust Company Americas, as depositary (the “Depositary”).

The Depositary, as depositary, or its nominee, will be the holder of the ordinary shares underlying your ADSs and you will have rights as provided in the Deposit Agreement, dated as of April 28, 2022, among us, the Depositary and all owners and holders from time to time of ADSs issued thereunder (the “Deposit Agreement”).

Subject to the terms of the Deposit Agreement and in compliance with the relevant requirements set out in the accompanying prospectus, you may turn in your ADSs to the Depositary for cancellation and withdrawal of the ordinary shares underlying your ADSs.

The Depositary will charge you fees for such cancellations pursuant to the Deposit Agreement.

You should carefully read the “Description of American Depositary Shares” section of the accompanying prospectus and the Deposit Agreement to better understand the terms of the ADSs.

**Ordinary shares (including ordinary shares represented by ADSs) to be outstanding after this offering**

37,514,630 ordinary shares (including ordinary shares represented by ADSs), or 37,855,539 ordinary shares (including ordinary shares represented by ADSs) if the underwriters exercise their option to purchase additional ADSs in full).

#### Offering price
The public offering price is US$154.00 per ADS.

#### Use of proceeds
We estimate that the proceeds to us from this offering will be